HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of aprindine, verapamil and nifedipine on ventricular fibrillation threshold in isolated rabbit hearts.

Abstract
The effect of aprindine, verapamil and nifedipine on electrical stimulation threshold (EST) and ventricular fibrillation threshold (VFT) was studied in isolated rabbit hearts. Aprindine steeply raised EST and VFT in a dose-dependent manner. With the highest concentration of aprindine tested (0.56 mumol/l), protection against electrically-induced ventricular fibrillation was achieved in 4 out of 6 hearts after 60 min exposure to the drug. Perfusion with verapamil (0.1 and 0.2 mumol/l) and nifedipine (0.14 and 0.21 mumol/l) produced significant rise in both thresholds. When the hearts were perfused with higher concentration (0.3 mumol/l verapamil, 0.28 mumol/l nifedipine), EST and VFT did not continue to be increased in a dose-dependent manner but actually dropped below the control value in most hearts. These results suggest that the effect of aprindine on EST and VFT is different from that of verapamil and nifedipine and further indicate a limited effectiveness of these two slow channel blockers against ventricular fibrillation.
AuthorsA A Almotrefi
JournalArchives internationales de pharmacodynamie et de therapie (Arch Int Pharmacodyn Ther) Vol. 274 Issue 1 Pg. 89-96 (Mar 1985) ISSN: 0003-9780 [Print] Belgium
PMID4015263 (Publication Type: Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Aprindine
  • Verapamil
  • Nifedipine
Topics
  • Animals
  • Aprindine (pharmacology)
  • Calcium Channel Blockers (pharmacology)
  • Electric Stimulation
  • Female
  • Heart Rate (drug effects)
  • In Vitro Techniques
  • Male
  • Nifedipine (pharmacology)
  • Rabbits
  • Ventricular Fibrillation (physiopathology)
  • Verapamil (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: